Nucleofill 20 Medium is a professional polynucleotide skin booster designed to support skin revitalisation and bio-restructuring. The formulation combines highly purified polynucleotides with a medium-viscosity gel structure to help improve hydration, skin quality, and tissue elasticity.
Suitable for a wide range of skin types, Nucleofill Medium is frequently incorporated into aesthetic treatment protocols targeting early signs of ageing, environmental skin stress, and reduced skin firmness. The product is valued for its hydrating, antioxidant, and biostimulating properties while maintaining a favourable safety profile associated with purified polynucleotide formulations.
Healthcare professionals seeking to buy Nucleofill Medium often select it for patients requiring skin quality enhancement without volumisation. Those researching Nucleofill 20 Medium, Nucleofill 20 eyes, or buy Nucleofill 20 commonly use it as part of regenerative aesthetic treatment plans.
Pricing is available to registered aesthetic professionals only.
Sign in to view pricesNucleofill 20, now commonly referred to as Nucleofill Medium, is a polynucleotide-based biostimulating injectable designed for professional aesthetic medicine applications. Developed by Promoitalia Medical Aesthetics, the product contains highly purified polynucleotides at a concentration of 20 mg/ml (2%), formulated to support skin revitalisation, hydration, and tissue quality improvement.
The product works through several complementary mechanisms. Polynucleotides help promote fibroblast activity, support extracellular matrix function, provide antioxidant protection against free radicals, and contribute to long-lasting hydration through water-binding properties. These actions are intended to improve skin elasticity, firmness, and overall skin quality while addressing signs associated with environmental stress and skin ageing.
Nucleofill Medium is typically used in patients presenting with dehydrated skin, mild-to-moderate wrinkles, loss of elasticity, oxidative stress-related skin changes, stretch marks, and superficial scars. It is supplied as a sterile injectable medical device for use exclusively by qualified healthcare professionals.
Nucleofill Medium belongs to the same category as other injectable skin quality products and biostimulators such as Profhilo®, Plenhyage®, and other polynucleotide-based regenerative treatments.
Compared with Profhilo®, which relies on stabilised hyaluronic acid for tissue hydration and remodelling, Nucleofill Medium uses purified polynucleotides as its primary active component. Both products aim to improve skin quality and hydration, but their biological mechanisms differ.
Compared with stronger polynucleotide formulations such as Nucleofill Strong, Nucleofill Medium contains a lower concentration and viscosity profile intended for patients with mild-to-moderate signs of ageing or dehydration.
Nucleofill Medium is also frequently compared with other regenerative injectables used around delicate facial areas, including protocols involving Nucleofill 20 eyes, although treatment selection should always be based on clinical assessment and manufacturer guidance.
This comparison is provided for clinical orientation only and does not imply interchangeability.
According to publicly available manufacturer and distributor documentation, Nucleofill Medium may be used for:
Treatment suitability should always be determined by a qualified healthcare professional.
Deep dermis bio-restructuring is referenced in publicly available manufacturer materials.
Not provided by manufacturer in publicly accessible documentation.
The product is supplied with:
Not provided by manufacturer in publicly available IFU documentation.
Some practitioners utilise multi-session protocols and maintenance treatments; however, these approaches are not included in the manufacturer’s publicly available official IFU guidance.
Nucleofill Medium should be administered only by qualified healthcare professionals trained in injectable aesthetic procedures and under appropriate aseptic conditions.
Not provided by manufacturer in publicly available documentation.
Not applicable.
No lidocaine reported in publicly available manufacturer information.
Nucleofill Medium is supplied as:
Not provided by manufacturer in publicly available documentation.
The duration of results is not provided by manufacturer in publicly available IFU documentation.
Clinical outcomes may vary according to skin condition, treatment protocol, patient characteristics, and practitioner assessment.
Publicly available product documentation provides limited contraindication information. Standard precautions include:
UKCA status: verify via current IFU or authorised distributor documentation.
Nucleofill 20 Medium is a polynucleotide-based injectable biostimulator designed to improve skin quality through hydration, antioxidant activity, and support of fibroblast function. The product contains 20 mg/ml purified polynucleotides and is intended for professional aesthetic use.
The polynucleotides contained within Nucleofill Medium help support extracellular matrix function, bind water molecules, and stimulate cellular processes associated with collagen and elastin production. The formulation also demonstrates antioxidant activity that may help protect tissues from oxidative stress.
Many aesthetic practitioners utilise polynucleotide treatments around delicate facial areas, and searches for Nucleofill 20 eyes are common. However, treatment suitability depends on clinical assessment, practitioner expertise, and official product guidance. Healthcare professionals should always follow manufacturer recommendations and applicable training protocols.
The manufacturer does not specify a definitive duration of effect in publicly available documentation. Clinical longevity varies depending on patient characteristics, treatment area, skin condition, and treatment protocol. Maintenance schedules should be determined by the treating practitioner.
Unlike hyaluronic acid-based skin boosters, Nucleofill Medium relies on purified polynucleotides. While both categories aim to improve hydration and skin quality, polynucleotides focus primarily on biostimulation, antioxidant activity, and regenerative support rather than HA-mediated tissue hydration alone.
Let’s talk on WhatsApp